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Versatile use of rtTA-expressing retroviruses in the study of 
neurodegeneration
Catia M. Teixeira, Jesús Ávila and María Llorens-Martín
The tetracycline-regulated transactivator (tTA) was 
used in combination with the E.coli tet operon (TetR) to 
induce the expression of target genes both in vivo and in 
vitro [1]. In this system, the activation of TetR occurs only 
after the binding of the tTA element. Thus, target genes 
will be overexpressed only in those cells in which TetR and 
tTA are co-expressed. Tissue or cell specificity depends on 
the promoter that drives the expression of tTA. In addition, 
the temporal control of gene expression is regulated by 
the presence of Tetracycline (or, more commonly, its 
analogue, Doxycycline, which crosses the blood-brain 
barrier easily). This molecule triggers a conformational 
change in tTA (natively active) that prevents its binding to 
TetR and suppresses transcription (tet-OFF system). More 
recently, variations in this system include the use of the 
reverse tetracycline-regulated transactivator (rtTA), which 
requires the presence of tetracycline to bind to tetR (tet-
ON system). 
Numerous combinations of mice engineered by tTA/
TetR systems have been generated in recent decades. In 
this regard, a model of particular relevance in the study 
of Alzheimer disease (AD) is the GSK-3β overexpressing 
(GSK-3β-OE) mouse [2]. This line is obtained by crossing 
tetR-GSK-3β mice (which carry a bi-directional TetR 
promoter followed by a GSK-3β cDNA in one direction 
and a cDNA encoding β-Galactosidase (β-Gal) fused to 
a nuclear localization signal in the other) with CamKII/
tTA mice. Thus, in the resulting GSK-3β-OE mice, this 
kinase is overexpressed in hippocampal and cortical 
neurons [3]. These mice exhibit increased neuronal Tau 
phosphorylation. Although these animals mimic several 
features of the AD brain scenario, the overexpression 
 Figure 1: The in vivo use of rtTA-expressing retroviruses. We have used an rtTA-IRES-GFP-expressing retrovirus (A) to 
deliver the rtTA element into the dividing newborn granule neurons of tetR-GSK-3β mice. After the binding of the tTA element to the 
TetR in the cells infected by the retroviruses, and in the presence of Doxycycline, GSK-3β will be selectively overexpressed in the 
target cells (B). By using this system we have obtained a rapid induction of GSK-3β overexpression in these cells (C). Furthermore, by 
combining this system with four weeks of voluntary exercise, we observed a markedly decreased (or even absent) cellular response to 
the stimulatory actions of physical exercise (D). 
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of a pathogenic protein in a general population of cells 
unavoidably triggers the activation of a series of non-cell-
autonomous consequences, such as neuroinflammation 
and microglial activation. These phenomena may act 
as a confounding factor and may hinder unambiguous 
conclusions regarding the specific contribution of a given 
protein to the neurodegenerative process. 
In order to avoid these indirect effects, and taking 
advantage of the fact that tTA can be delivered to target 
cells by viral vectors, we have recently developed a novel 
strategy, which, to the best of our knowledge, has not been 
applied to the study of neurodegenerative processes in the 
CNS. This strategy is based on the use of tetR-GSK-3β 
mice and the hippocampal delivery of rtTA by means of 
an rtTA-IRES-GFP-expressing retrovirus (Figure 1A). 
Using this system, we achieved rapid and selective in vivo 
overexpression of GSK-3β in the hippocampal neurons 
infected by the retrovirus (Figure 1B). 
The in vivo use of retroviral vectors in the CNS 
became generalized after the seminal work by F.H. Gage 
and collaborators [4]. These authors demonstrated the 
resulting infection of dividing newborn granule neurons, 
a cell population subjected to continuous neurogenesis 
throughout life. Adult hippocampal neurogenesis (AHN) 
is severely damaged in AD patients [5]. In this regard, 
we showed that the injection of an rtTA-expressing 
retrovirus into the hippocampus of tetR-GSK-3β mice 
causes a dramatic cell-autonomous alteration of newborn 
granule neuron morphology and connectivity. It should be 
noted that GSK-3β overexpression can be monitored by 
means of two reporter proteins, namely EGFP (encoded 
by the retroviral genome) and β-Gal (encoded by murine 
genome). In addition, we detected an increase in the 
levels of Tau phosphorylation in EGFP+/β-Gal+ cells [6]. 
In addition, by combining this system with four weeks of 
voluntary exercise, we observed a markedly decreased (or 
even absent) cellular response to the stimulatory actions 
of physical exercise (C). These data further confirm the 
pivotal role played by GSK-3β in regulating not only the 
physiological maturation of newborn granule neurons but 
also their response to external stimuli. 
In summary, the delivery of tTA by means of 
viral vectors has three major advantages with respect 
to classical murine lines. First, it is straightforward to 
generate viral constructs in which the expression of the 
tTA element is driven by specific promoters; second, the 
use of different types of viral vector (either retro- lenti- 
or adeno-associated- viruses) allows higher flexibility in 
terms of the cellular populations infected; and, last but 
not least, the use of this type of vector (especially in the 
case of retroviruses) almost completely removes non-
cell-autonomous effects derived from the expression of 
pathologic proteins in a wide range of cell populations. 
Hence, we propose that the use of viral vectors 
expressing either tTA or rtTA elements in combination 
with tetR mouse models will contribute to improving 
our knowledge of the cell-autonomous effects of proteins 
thought to be pathological in certain contexts. In addition, 
these data may contribute to the design successful 
treatments for, but not limited to, neurodegenerative 
disorders.
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